In July 2019, Belfast-based medtech firm axial3D announced that it has successfully raised $3m (£2.4m) to further its existing reach into the US market.
A number of senior appointments have since been made to support this strategy. Daniel Crawford, the company’s founder will take on the post of Chief Strategy Officer. He has appointed current board member Roger Johnston as CEO, and US-based Rob Fisher to the role of Vice President of Business Development.
Roger has held senior roles in a broad range of companies including Accenture, IBM, Meridio and most recently Vice President of Business Development for Kainos Digital Services. He said: “I am truly delighted to be taking up the post of CEO for axial3D. This is one of the most exciting technology innovations that I have seen in my 33 years in IT and I am just so excited by its potential to changing the lives of patients around the world.”
Rob's career spans over 36 years in the healthcare industry. Most recently he served as Service Line Administrator at Tallahassee Memorial Healthcare and before that Vice President of Business Development for InTouch Health in California. On his appointment, he commented: “I worked with axial3D in Tallahassee Memorial Healthcare as a customer and directly saw the transformative impact that their 3D models can have on how surgeries are planned and how clinical outcomes can be transformed for patients. My aim is to help make axial3D a true market leader in this area.”
Originating as a start-up on the Northern Ireland tech scene, axial3D specialises in automated 3D printing solutions for healthcare and helps surgeons to improve outcomes in complex cases around the world. The firm has been nominated for, and won numerous accolades, the most recent being ‘Best Use of AI in Health’ at European DatSci Awards 2019.
